Results 31 to 40 of about 33,124 (331)
Strategies to Incorporate Left Atrial Appendage Occlusion Into Clinical Practice [PDF]
, 2014 The left atrial appendage (LAA) has been identified as a predominant source of thrombus formation leading to significant thromboembolic events in patients with nonvalvular atrial fibrillation.
Alli, Oluseun +2 more
core +1 more source
Frontiers in Cardiovascular Medicine, 2023 IntroductionAtrial Septal Defect/Patent Foramen Ovale (ASD/PFO) occlusion is performed to prevent paradoxical embolism and reduce the risk of recurrent ischemic stroke.
Yi Song +4 more
doaj +1 more source
- LAA Occluder View for post-implantation Evaluation (LOVE) - standardized imaging proposal evaluating implanted left atrial appendage occlusion devices by cardiac computed tomography [PDF]
, 2016 Background: A standardized imaging proposal evaluating implanted left atrial appendage (LAA) occlusion devices by cardiac computed tomography angiography (cCTA) has never been investigated.
Akin, Ibrahim +9 more
core +1 more source
JACC Clinical Electrophysiology, 2023 BACKGROUND Device-related thrombus (DRT) after left atrial appendage closure (LAAC) procedures is a rare but potentially serious event. Thrombogenicity and delayed endothelialization play a role in the development of DRT.
W. Saliba +16 more
semanticscholar +1 more source
Атеротромбоз, 2019 The article demonstrates a clinical case of forced renewal of anticoagulant therapy after the endovascular closure of the left atrial appendage. Patient with atrial fibrillation and high risk of thromboembolic complications and bleeding on the background
R. V. Guchaev +7 more
doaj +1 more source
A brief overview of surgery for atrial fibrillation [PDF]
, 2014 The Maze procedure was the first surgical technique developed to ablate, rather than isolate, atrial fibrillation and was first performed clinically in 1987.
Cox, James L
core +2 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background Cerebral microbleeds (CMBs) are increasingly recognized as “covert” brain lesions indicating increased risk of future neurological events. However, data on CMBs in patients undergoing catheter‐based structural heart interventions are scarce ...
Tim Bastian Braemswig +18 more
doaj +1 more source
Percutaneous left atrial appendage occlusion: putting the most lethal human attachment behind bars [PDF]
, 2012 Hospital Israelita Albert EinsteinUniversidade Federal de São Paulo (UNIFESP) Escola Paulista de MedicinaCardiovascular Research FoundationUNIFESP ...
Caixeta, Adriano +2 more
core +3 more sources
Frontiers in Cardiovascular Medicine, 2022 Left atrial appendage closure (LAAC) devices can be inadvertently released into unfavorable locations, which may allow them to migrate to a different position within the left atrial appendage or embolize from the heart into the aorta.
Saihua Wang +5 more
doaj +1 more source
Percutaneous retrieval of a dislodged watchman left atrial appendage closure device
Cardiology Plus, 2016 A 46-year-old female underwent left atrial appendage closure (LAAC) with a Watchman LAAC device. During the procedure, the device embolized into the descending aorta. A new device was implanted to the left atrial appendage complete the closure.
Jiangtao Yu +3 more
doaj +1 more source